Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat Media The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Submitted by Chris Markoch. First Published: 1/18/2026. 
What You Need to Know - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. They often include companies with disruptive technologies, exposure to emerging trends, or compelling turnaround stories. Many of these firms will never scale or survive, but if even one succeeds, investors can see outsized returns. For investors who believe there is strength in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While that is no guarantee of success, it can help provide additional conviction. A former hedge fund manager known for cutting through market noise is briefly opening access to his flagship trading strategy. In a short demo, he explains how his "One Ticker" approach works — and how readers can access the full service for a year at a steep discount. Watch the brief demo here Some investors define penny stocks as any shares trading for $5 or less. The screener used here follows the traditional definition: stocks priced below $1. These names are highly volatile—conduct your own research and confirm your risk tolerance before taking a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus, and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case for Vaxart hinges on its novel delivery approach. If the company achieves FDA approval and successfully scales manufacturing and distribution, its oral vaccines could reduce logistical barriers to mass immunization and create licensing opportunities. Positive trial results or a commercial collaboration could materially change sentiment and valuation from a relatively low base. That said, clinical risk is the principal challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from larger, well-funded players also constrains visibility. At present, Vaxart is a long-term speculative play on platform validation rather than near-term profitability. MarketBeat analyst coverage of Vaxart is limited to a single analyst, which may be a red flag for some investors. Institutional ownership stands at about 18%. On the positive side, VXRT has only around 2% short interest, which could somewhat dampen extreme volatility. Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software solutions enable the precise 3D mapping needed for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on producing compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision rests on continued progress toward vehicle automation and potential partnerships with major OEMs. If MVIS can demonstrate performance or cost advantages, it could land supply agreements or licensing deals that materially improve revenue visibility. The technology also has applications beyond vehicles—robotics and smart city infrastructure could provide additional growth paths. Despite the promise, Microvision faces strong competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). Commercial adoption of LiDAR has experienced delays, and the route to sustained profitability remains uncertain. MVIS is covered by three analysts and carries a consensus price target of $2.50, implying roughly 169% upside from its Jan. 15 closing price. That said, Microvision shows relatively low institutional ownership (around 30%) and high short interest (about 21%), factors that can contribute to pronounced volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems often overlook. The bullish case for Datavault AI centers on its niche focus and scalability potential. As data gains value, businesses and individuals increasingly look for secure ways to monetize digital information. Datavault's platform could benefit from broader AI adoption and heightened emphasis on data sovereignty. Early traction or strategic partnerships could act as catalysts for investor confidence. Still, Datavault AI operates in a highly experimental space. Its business model is evolving, and the path to meaningful revenue is unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should treat it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
| 
